ChemoCentryx, Inc. - stock earnings
Stock symbol CCXI is outdated, potentially delisted? Maybe it is available on other exchange?
CCXI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -31.7 million USD | 11.8 million USD |
| 2022Q1 | -38.6 million USD | 5.5 million USD |
| 2021Q4 | -40.5 million USD | 2.3 million USD |
| 2021Q3 | -22.3 million USD | 17.7 million USD |
| 2021Q2 | -39.2 million USD | 1.8 million USD |
| 2021Q1 | -29.7 million USD | 10.4 million USD |
| 2020Q4 | -29.9 million USD | 4.4 million USD |
| 2020Q3 | -24.1 million USD | 5.1 million USD |
| 2020Q2 | 20.3 million USD | 49.4 million USD |
CCXI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -131.8 million USD | 32.2 million USD |
| 2020 | -55.4 million USD | 64.9 million USD |
| 2019 | -55.5 million USD | 36.1 million USD |
| 2018 | -38.0 million USD | 42.9 million USD |
| 2017 | 17.9 million USD | 82.5 million USD |
CCXI
Price: $51.99
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.66 USD
P/E Ratio: -91.33
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.0 million
Ebitda: -6.8 millionMarket Capitalization: 3.7 billion